Skip to main content

Full text of "USPTO Patents Application 10643431"

See other formats


United States Patent and Trademark Office 



UNITED STATES DEPARTMENT OF COMMERCE 
United States Patent and Trademark Office 
Addnas: COMMISSIONER FOR PATENTS 
P.O.Box 1450 

Alexandria, Viiginia 22313-1450 
ww.uspto.gov 



APPLICATION NO. 


FILING DATE 


FIRST NAMED INVENTOR 


ATTORNEY DOCKET NO. 


CONFIRMATION NO. 


10/643,431 


08/19/2003 


Elizabeth R. Oldham 


DX0934K1B 


4687 



24265 7590 07/12/2005 

SCHERING-PLOUGH CORPORATION 
PATENT DEPARTMENT (K-6- 1 , 1 990) 
2000 GALLOPING HILL ROAD 
KENILWORTH, NJ 07033-0530 



EXAMINER 



MERTZ, PREMA MARIA 



ART UNIT 



PAPER NUMBER 



1646 

DATE MAILED: 07/12/2005 



Please find below and/or attached an Office communication concerning this application or proceeding. 



PTO-90C (Rev. 10/03) 



Notice of Abandonment 


Application No. 
10/643,431 


Applicant(s) 
OLDHAM ET AL. 


Examiner 

Mertz, Prema Maria 


Art Unit 
1646 





The MAILING DATE of this communication appears on the cover sheet with the correspondence address- 



This application is abandoned in view of 

1. □ Applicant's failure to timely file a proper reply to the Office letter mailed on . 

(a) □ A reply was received on (with a Certificate of Mailing or Transmission dated ), which is after the expiration of the 

period for reply (including a total extension of time of month(s)) which expired on . 

(b) □ A proposed reply was received on , but it does not constitute a proper reply under 37 CFR 1 .1 13 (a) to the final rejection. 

(A proper reply under 37 CFR 1.1 13 to a final rejection consists only of. (1) a timely filed amendment which places the 
application in condition for allowance; (2) a timely filed Notice of Appeal (with appeal fee); or (3) a timely filed Request for 
Continued Examination (RCE) in compliance with 37 CFR 1.114). 

(c) □ A reply was received on but it does not constitute a proper reply, or a bona fide attempt at a proper reply, to the non- 

final rejection. See 37 CFR 1.85(a) and 1.111. (See explanation in box 7 below). 

(d) □ No reply has been received. 



2. □ Applicant's failure to timely pay the required issue fee and publication fee, if applicable, within the statutory period of three months 
from the mailing date of the Notice of Allowance (PTOL-85). 

(a) □ The issue fee and publication fee, if applicable, was received on (with a Certificate of Mailing or Transmission dated 

), which is after the expiration of the statutory period for payment of the issue fee (and publication fee) set in the Notice of 

Allowance (PTOL-85). 

(b) □ The submitted fee of $ is insufficient. A balance of $ is due. 

The issue fee required by 37 CFR 1.18 is $ . The publication fee, if required by 37 CFR 1.18(d), is $ . 

(c) □ The issue fee and publication fee, if applicable, has not been received. 

30 Applicant's failure to timely file corrected drawings as required by, and within the three-month period set in, the Notice of 
Allowability (PTO-37). 

(a) □ Proposed corrected drawings were received on (with a Certificate of Mailing or Transmission dated ), which is 

after the expiration of the period for reply. 

(b) □ No corrected drawings have been received. 



4. H The letter of express abandonment which is signed by the attorney or agent of record, the assignee of the entire interest, or all of 

the applicants. 

5. □ The letter of express abandonment which is signed by an attorney or agent (acting in a representative capacity under 37 CFR 

1.34(a)) upon the filing of a continuing application. 

6. □ The decision by the Board of Patent Appeals and Interference rendered on and because the period for seeking court review 

of the decision has expired and there are no allowed claims. 

7. □ The reason(s) below A 




Barbara ^Debnam 
Management & Program Analyst 
Art Unit: 3900 

Petitions to revive under 37 CFR 1 .1 37(a) or (b), or requests to withdraw the holding of abandonment under 37 CFR 1.181, should be promptly filed to 
minimize any negative effects on patent term. 



U.S. Patent and Trademark Office 

PTOL-1432 (Rev. 04-01) 



Notice of Abandonment 



Part of Paper No. 0